Federal contract award

75N95021P00653

RETENTION AND NOVEL OUTCOMES IN HARMONIZED RANDOMIZED CONTROLLED TRIALS OF STIMULANT USE DISORDER TREATMENTS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIDA
NAICS541990 — All Other Professional, Scientific, and Technical Services
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$49.8K
Current contract value$49.8K
Potential contract value / ceiling$49.8K
Start dateSep 21, 2021
Current end dateSep 21, 2022
Potential end dateSep 21, 2022
Latest award activitySep 10, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 10, 2026P00003$-166TO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
Mar 2, 2022P00002$0RETENTION AND NOVEL OUTCOMES IN HARMONIZED RANDOMIZED CONTROLLED TRIALS OF STIMULANT USE DISORDER TREATMENTS
Oct 18, 2021P00001$0EO14042 RETENTION AND NOVEL OUTCOMES IN HARMONIZED RANDOMIZED CONTROLLED TRIALS OF STIMULANT USE DISORDER TREATMENTS
Sep 21, 20210$49.9KRETENTION AND NOVEL OUTCOMES IN HARMONIZED RANDOMIZED CONTROLLED TRIALS OF STIMULANT USE DISORDER TREATMENTS

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.